Exploring the inhibitory potential of novel piperidine-derivatives against main protease (M(pro)) of SARS-CoV-2: A hybrid approach consisting of molecular docking, MD simulations and MMPBSA analysis

探索新型哌啶衍生物对SARS-CoV-2主蛋白酶(M(pro))的抑制潜力:一种结合分子对接、分子动力学模拟和MMPBSA分析的混合方法

阅读:1

Abstract

In the current study, a hybrid computational approach consisting of different computational methods to explore the molecular electronic structures, bioactivity and therapeutic potential of piperidine compounds against SARS-CoV-2. The quantum chemical methods are used to study electronic structures of designed derivatives, molecular docking methods are used to see the most potential docking interactions for main protease (M(Pro)) of SARS-CoV-2 while molecular dynamic and MMPBSA analyses are performed in bulk water solvation process to mimic real protein like aqueous environment and effectiveness of docked complexes. We designed and optimized piperidine derivatives from experimentally known precursor using quantum chemical methods. The UV-Visible, IR, molecular orbitals, molecular electrostatic plots, and global chemical reactivity descriptors are carried out which illustrate that the designed compounds are kinetically stable and reactive. The results of MD simulations and binding free energy revealed that all the complex systems possess adequate dynamic stability, and flexibility based on their RMSD, RMSF, radius of gyration, and hydrogen bond analysis. The computed net binding free energy (ΔGbind ) as calculated by MMPBSA method for the complexes showed the values of -4.29 kcal.mol(-1) for P1, -5.52 kcal.mol(-1) for P2, -6.12 kcal.mol(-1) for P3, -6.35 kcal.mol(-1) for P4, -5.19 kcal.mol(-1) for P5, 3.09 kcal.mol(-1) for P6, -6.78 kcal.mol(-1) for P7, and -6.29 kcal.mol(-1) for P8.The ADMET analysis further confirmed that none of among the designed ligands violates the Lipinski rule of five (RO5). The current comprehensive investigation predicts that all our designed compounds are recommended as prospective therapeutic drugs against M(pro) of SARS-CoV-2 and it provokes the scientific community to further perform their in-vitro analysis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。